Stifel Upgrades FibroGen (FGEN) to Buy
Tweet
Share
E-mailGet Alerts FGEN Hot Sheet
Price: $9.71 --0%
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Stifel analyst Annabel Samimy upgraded FibroGen (NASDAQ: FGEN) from Hold to Buy with a price target of $28.00 (from $23.00).
For an analyst ratings summary and ratings history on FibroGen click here. For more ratings news on FibroGen click here.
Shares of FibroGen closed at $17.32 yesterday.
You May Also Be Interested In
- Citi Upgrades The Macerich Company (MAC) to Buy
- ACM Research, Inc. (ACMR) PT Raised to $130 at Morgan Stanley
- Axis Capital Limited Upgrades Infosys Ltd. (INFO:IN) (INFY) to Buy (1)
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
